Skip to main content
    C

    Catheter Precision Inc. (VTAK)

    Official site

    HEALTHCARE • MEDICAL DEVICES • AMEX

    $0.15
    +0.00 (+0.00%)

    Market Cap: $286,480

    Last updated: Oct 09, 2026 at 5:00 PM ET

    Catheter Precision Inc. (VTAK) Financials: Revenue, Profit and Cash Flow

    Updated Sep 30, 2026. Financial statements from company filings, amounts in US dollars.

    Catheter Precision reported revenue of $819.00K for the fiscal year ended Dec 31, 2025, up 95.0% from the year before. That year, net income was -$17.70M with a net margin of -2160.6%, operating cash flow was -$8.30M and free cash flow was -$8.31M. The quarter ended Sep 30, 2026 had revenue of $1.84M and net income of -$15.12M.

    Revenue and Margins

    Over the 9 years to Dec 2025, revenue fell from $5.98M, a compound annual decline of 19.8%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$819.00K+95.0%92.3%-2581.6%-2160.6%
    Dec 2024$420.00K-5.0%90.0%-2676.9%-3962.6%
    Dec 2023$442.00KN/A93.2%-17674.0%-15966.5%
    Dec 2022$0-100.0%N/AN/AN/A
    Dec 2021$22.00K+340.0%-6990.9%-133027.3%-113954.5%
    Dec 2020$5.00K-99.9%-38260.0%-708020.0%-1441760.0%
    Dec 2019$7.20M+15.1%-22.9%-801.9%-791.2%
    Dec 2018$6.26M+6.6%32.8%-498.0%-492.8%
    Dec 2017$5.87M-1.8%29.0%-302.6%-302.6%
    Dec 2016$5.98MN/A47.5%-70.2%-70.3%
    Annual, fiscal years ended Dec 2016 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, the net loss widened from the year before. In the quarter ended Sep 2026, the net loss widened from the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Revenue$819.00K$420.00K$442.00K$0$22.00K$5.00K$7.20M$6.26M$5.87M$5.98M
    Cost of revenue$63.00K$42.00K$30.00K$161.00K$1.56M$4.34M$8.85M$4.21M$4.17M$3.14M
    Gross profit$756.00K$378.00K$412.00K-$147.00K-$1.54M-$1.91M-$1.65M$2.05M$1.71M$2.84M
    Research and development$2.83M$272.00K$475.00K$6.39M$12.25M$8.96M$4.53M$2.78M$4.52M$1.72M
    Operating income-$21.14M-$11.24M-$78.12M-$26.96M-$29.27M-$35.40M-$57.73M-$31.16M-$17.76M-$4.20M
    Net income-$17.70M-$16.64M-$70.57M-$26.86M-$25.07M-$72.09M-$56.96M-$30.83M-$17.77M-$4.20M
    EBITDA-$13.84MN/A-$68.84M-$26.44M-$27.71M-$32.86M-$55.98M-$30.54M-$17.54M-$4.10M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Revenue$1.84M$1.02M$432.00K$238.00K$0$212.00K$143.00K$149.00K$96.00K$93.00K$82.00K$128.00K
    Gross profit$324.00K$98.00K$390.00K$218.00K$0$198.00K$132.00K$138.00K$86.00K$77.00K$77.00K$121.00K
    Operating income-$2.46M-$3.96M-$2.32M-$9.86M-$1.19M-$4.69M-$3.58M-$3.05M-$2.86M-$2.72M-$2.62M-$2.60M
    Net income-$15.12M-$3.31M-$1.69M-$5.85M-$2.34M-$5.46M-$4.04M-$5.63M-$4.12M-$4.22M-$2.67M-$669.00K
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, total debt of $3.38M exceeded cash and equivalents by $3.29M.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Total assets$15.86M$27.77M$30.74M$16.84M$21.04M$33.44M$44.08M$74.03M$11.27M$5.84M
    Current assets$390.00K$3.29M$4.16M$16.84M$17.09M$27.62M$36.00M$69.23M$10.04M$5.31M
    Cash and equivalents$88.00K$2.87M$3.56M$15.86M$15.04M$23.91M$14.58M$64.31M$8.24M$3.92M
    Total liabilities$9.21M$16.01M$9.54M$7.58M$7.37M$12.29M$10.93M$7.33M$18.88M$6.22M
    Short-term debt$298.00K$177.00K$184.00K$0$283.00K$421.00K$0$293.00K$44.00K$42.00K
    Long-term debt$3.08M$1.56M$0N/AN/A$1.58M$265.00KN/AN/AN/A
    Shareholder equity$7.05M$11.76M$21.19M$9.26M$13.67M$21.15M$33.15M$66.70M-$7.62M-$380.00K
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total assets$24.23M$36.87M$35.09M$15.86M$25.47M$25.56M$24.80M$27.77M$26.75M$26.26M$28.02M$30.74M
    Total liabilities$12.54M$19.73M$25.93M$9.21M$19.02M$19.01M$16.88M$16.01M$13.92M$11.94M$9.50M$9.54M
    Cash and equivalents$2.39M$643.00K$441.00K$88.00K$1.07M$838.00K$450.00K$2.87M$1.27M$16.00K$1.49M$3.56M
    Shareholder equity$12.13M$17.56M$9.57M$7.05M$6.78M$6.79M$7.92M$11.76M$12.83M$14.32M$18.52M$21.19M
    Last 12 quarters

    Cash Flow

    Operating cash flow was negative in the fiscal year ended Dec 2025.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Operating cash flow-$8.30M-$9.27M-$20.62M-$22.57M-$27.63M-$28.30M-$33.17M-$18.51M-$5.52M-$1.89M
    Capital expenditures$17.00K$67.00K$76.00K$17.00K$265.00K$67.00K$268.00K$582.00K$547.00K$210.00K
    Free cash flow-$8.31M-$9.34M-$20.70M-$22.59M-$27.89M-$28.37M-$33.44M-$19.09M-$6.07M-$2.10M
    Dividends paidN/A$5.16MN/A$907.16KN/AN/AN/AN/AN/AN/A
    Share repurchasesN/AN/A$640.00K$1.25MN/AN/AN/A$3.56MN/AN/A
    Investing cash flow$167.00K-$67.00K-$61.00K$21.00K$3.80M$15.93M-$16.03M-$582.00K-$547.00K-$210.00K
    Financing cash flow$5.34M$8.65M$8.39M$23.36M$14.96M$21.69M-$526.00K$75.17M$10.39M$5.37M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Operating cash flow-$4.50M-$2.86M-$2.80M-$1.51M-$2.18M-$2.26M-$2.34M-$2.86M-$2.77M-$1.70M-$1.94M-$1.89M
    Capital expenditures$73.00K$15.00K$6.00K$82.00K$7.00K$7.00K$10.00K$0$1$45.00K$22.00K$18.00K
    Free cash flow-$4.57M-$2.88M-$2.80M-$1.59M-$2.19M-$2.27M-$2.35M-$2.86M-$2.77M-$1.74M-$1.96M-$1.91M
    Last 12 quarters

    Frequently Asked Questions About VTAK

    What is Catheter Precision's annual revenue?

    Catheter Precision reported revenue of $819.00K for the fiscal year ended Dec 31, 2025.

    How fast is Catheter Precision's revenue growing?

    Revenue was up 95.0% for the fiscal year ended Dec 31, 2025 compared with the year before.

    Is Catheter Precision profitable?

    No. Catheter Precision reported net income of -$17.70M for the fiscal year ended Dec 31, 2025, with a net margin of -2160.6%.

    How much free cash flow does VTAK generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of -$8.30M minus capital expenditures of $17.00K produced free cash flow of -$8.31M.

    How much debt does Catheter Precision have?

    The balance sheet dated Dec 31, 2025 reported long-term debt of $3.08M, short-term debt of $298.00K and cash and equivalents of $88.00K.